Showing Results for
- Academic Journals (5)
From:Journal of Immunology Research (Vol. 2022) Peer-ReviewedSevere acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) virus is the cause of coronavirus disease 2019 (COVID-19). It has caused millions of infections and deaths globally over a 2-year period. Some populations...
From:PLoS ONE (Vol. 15, Issue 7) Peer-ReviewedHIV-associated/epidemic Kaposi's sarcoma (EpKS) is an AIDS-defining angio-proliferative malignancy. It can be treated with antiretroviral therapy (ART) alone or with ART plus cytotoxic chemotherapy. ART-treated EpKS can...
From:PLoS ONE (Vol. 13, Issue 7) Peer-ReviewedSubtype C HIV-1 is responsible for the largest proportion of people living with HIV-1 infection. However, there is limited information about the roles of the brain and its cell types as a potential sanctuary for this...
From:PLoS ONE (Vol. 7, Issue 3) Peer-Reviewed
Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep PyrosequencingAuthor(s): For Yue Tso 1 , Damien C. Tully 1 , Sandra Gonzalez 1 , Christopher Quince 6 , On Ho 2 , Patricia Polacino 3 , Ruth M. Ruprecht 4 , 5 , Shiu-Lok Hu 2 , 3 , Charles Wood 1 , * Introduction The envelope...
From:PLoS ONE (Vol. 16, Issue 3) Peer-ReviewedBackground Neutralizing-antibody (nAb) is the major focus of most ongoing COVID-19 vaccine trials. However, nAb response against SARS-CoV-2, when present, decays rapidly. Given the myriad roles of antibodies in immune...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it